🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excellent presentation by Dave Cash showing amyloid and tau PET data from our LHA @ UCL Insight 46 data led by Will Coath and funded by Marc Zacher Alzheimer's Association Research at ARUK

Latest from the Insight 46 team *open access* @BrainComms — normal appearing white matter is not always normal … academic.oup.com/braincomms/art… Dr Sarah-Naomi James 🏴󠁧󠁢󠁷󠁬󠁳󠁿 Prof Jo Barnes also at @jbar-uk.bsky.social UCL Brain Sciences LHA @ UCL DRC@UCL Research at ARUK Alzheimer's Association

I am so honoured to have been able to nominate Jason Warren of the Brain Behaviour Group DRC@UCL RareDementiaSupport for this RCSLT 💙 honorary fellowship! He has always advocated 4 the needs of people with #PPA & the role of #SLT & I personally am so grateful for his ongoing mentorship.

The program for the Research at ARUK Alzheimer's Research UK Clinical Conference 2023 is now confirmed. Book your place today, and join us on Friday 10th November in London alzheimers.eventsair.com/clinical-confe…

It was wonderful to welcome @SteveJamieson12 CEO of RCSLT 💙 to observe the role of #SLT in the dementia cognitive disorders clinic today NHNN Therapy & Rehabilitation DRC@UCL - thanks for coming!!!!

Out today and *open access* — our large international study of posterior cortical atrophy — a distinctive syndrome almost always due to Alzheimer’s The Lancet Neurology UCSF MAC Mayo Clinic UCL Queen Square Institute of Neurology UCL Brain Sciences Alzheimer's Association Alzheimercentrum Amsterdam (inactief) thelancet.com/action/showPdf…

Dr Prof Cath Mummery (UCL Queen Square Institute of Neurology), head of clinical trials at the DRC@UCL, has been announced as the Director of a new network of #dementia trial sites across the country. Read more ⬇️ bit.ly/47VlYKH

Our paper on iatrogenic #alzheimerdisease out today Nature Medicine Detailed summary & links below. TLDR: 5 tragic cases resulting from a very rare medical procedure stopped in 1985. No risk of person to person spread; hopefully will provide major insights into Alzheimer biology

We are pleased to have been able to contribute to this largest ever international study of PCA posterior cortical atrophy RareDementiaSupport Keir Yong Jonathan Schott thelancet.com/journals/laneu…

ICYMI: "For the first time, we've got drugs that show that you can alter the course of Alzheimer's disease, and that's an extraordinary thing" Dr Prof Cath Mummery DRC@UCL discusses the potential impact of new #Alzheimers treatments. 📺Watch on BBC Panorama bbc.in/48vJgqR

Great to hear Dr Prof Cath Mummery talk to Fergus Walsh about new #Alzheimer's drugs lecanemab and donanemab in BBC Panorama's Alzheimer’s: A Turning Point, and to hear patient experiences. Watch it here ⬇️ bbc.co.uk/iplayer/episod…

Great to announce that teams UCL Queen Square Institute of Neurology and Dementias Platform UK have both been awarded the Blood Biomarker Challenge. The UCL team will test the diagnostic utility of ptau217 for Alzheimer’s in @NHS memory clinics Alzheimer's Society Alzheimer's Research UK National Institute for Health and Care Research BBC Radio 4 Today UK Dementia Research Institute

📺Watch 'The Jennings vs Alzheimer's' on BBC Two tonight at 9pm 📺 Find out how experts, inc. Prof Sir John Hardy, Prof Nick Fox, and Dr Prof Cath Mummery DRC@UCL have shed light on #AlzheimersDisease, its causes and potential cures, for #DementiaActionWeek ucl.ac.uk/news/2024/may/…

I had the pleasure of joining Gabby Logan for a dementia themed episode of The Mid•Point podcast — we discuss how to reduce your risk, new treatments, blood tests for Alzheimer’s, and more. Available, wherever you get your podcasts podfollow.com/midpoint/view

Out today in The Lancet Neurology — we review excess brain volume loss following amyloid immunotherapy and conclude that it is *not* related to neuronal loss. Download here: authors.elsevier.com/c/1jnzE5FFzL0E… #ARPA Chris Belder The Lancet Neurology

In our latest *open access* LHA @ UCL paper we explore the phenomenon of accelerated forgetting in the Insight 46 cohort Brain academic.oup.com/brain/article/…

Involved in dementia diagnosis and unsure about genetic testing– an outline of how to approach to diagnostic testing in commonly diagnosed dementias DRC@UCL The Neurogenetics Lab ION TUH Neurology Antoinette O Connor Chris Belder Natalie Ryan Jon Rohrer Nayana Lahiri

4 yr fully-funded PhD* to understand how dementia causes 'brainsight' loss in the largest imaging-genetics study (UK Biobank) & posterior cortical atrophy (visual variant Alzheimer's): tinyurl.com/te9snjdx * Engineering and Physical Sciences Research Council * The National Brain Appeal DRC@UCL RareDementiaSupport UCL Queen Square Institute of Neurology COMBINE Lab@UCL

The world's first Rare Dementia Support Centre is under construction. Made up of five floors across two adjoining Georgian townhouses, the new space will be changing lives from 2026. Read more and see the virtual guided tour here: raredementiasupport.org/news/rds-centr… #DementiaActionWeek

Hearing loss is one of the 14 modifiable risk factors for dementia, but how the two are connected remains a mystery. Dr. Chris Hardy, the second Alzheimer’s Society Carol Jennings Fellow, is using his groundbreaking research to explore this vital link and how changes in hearing